[1]Kindon,Nicholas;Andrews,Glen;Baxter,Andrew;Cheshire,David;Hemsley,Paul;Johnson,Timothy;Liu,Yu-Zhen;McGinnity,Dermot;McHale,Mark;Mete,Antonio;Reuberson,James;Roberts,Bryan;Steele,John;Teobald,Barry;Unitt,John;Vaughan,Deborah;Walters,Iain;Stocks,MichaelJ.[ACSMedicinalChemistryLetters,2017,vol.8,#9,p.981-986]
[2]CurrentPatentAssignee:ASTRAZENECAPLC-WO2007/69978,2007,A1Locationinpatent:Page/Pagecolumn28
[1]Kindon,Nicholas;Andrews,Glen;Baxter,Andrew;Cheshire,David;Hemsley,Paul;Johnson,Timothy;Liu,Yu-Zhen;McGinnity,Dermot;McHale,Mark;Mete,Antonio;Reuberson,James;Roberts,Bryan;Steele,John;Teobald,Barry;Unitt,John;Vaughan,Deborah;Walters,Iain;Stocks,MichaelJ.[ACSMedicinalChemistryLetters,2017,vol.8,#9,p.981-986]
[1]Kindon,Nicholas;Andrews,Glen;Baxter,Andrew;Cheshire,David;Hemsley,Paul;Johnson,Timothy;Liu,Yu-Zhen;McGinnity,Dermot;McHale,Mark;Mete,Antonio;Reuberson,James;Roberts,Bryan;Steele,John;Teobald,Barry;Unitt,John;Vaughan,Deborah;Walters,Iain;Stocks,MichaelJ.[ACSMedicinalChemistryLetters,2017,vol.8,#9,p.981-986]
[1]ACSMedicinalChemistryLetters,2017,vol.8,p.981-986
[1]ACSMedicinalChemistryLetters,2017,vol.8,p.981-986
Title: Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists.
Journal: ACS medicinal chemistry letters 20170914
Title: Kindon N, et al. Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists. ACS Med Chem Lett. 2017 Sep 1;8(9):981-986.
Title: Asher Mullard. Cancer charity sees success re-prioritizing industry's shelved compounds. Nat Rev Drug Discov. 2014 May;13(5):319-21.
